2-Methylpentanoic acid

2-Methylpentanoic acid (CAS No.: 97-61-0) is a naturally occurring branched short chain fatty acid metabolite, also known as 2 methylvaleric acid, that is primarily categorized as a microbiome associated metabolic signaling molecule for studies of host microbe crosstalk, immunometabolism, and biomarker discovery in life sciences and drug discovery workflows; current evidence indicates it can arise from gut microbial catabolism of branched chain amino acids and has been investigated as a fecal metabolite linked to metabolic dysfunction phenotypes, with reports of reduced abundance in diabetic mouse models supporting its use in translational metabolomics panels rather than as a standalone diagnostic marker; mechanistically, available literature and class based inference for short chain fatty acids suggest modulation of G protein coupled receptor signaling and inhibition of histone deacetylase activity, thereby influencing pathways connected to cellular energy homeostasis, inflammatory tone, and epigenetic regulation, although isoform selective potency and pathway dominance remain context dependent and require assay specific validation; because publicly reported quantitative pharmacology for this specific molecule is limited, activity is typically described qualitatively or by analogy to related short chain fatty acids with effects often observed from high nanomolar to millimolar exposure windows depending on endpoint sensitivity, matrix effects, and model system, and robust characterization generally requires orthogonal readouts such as receptor reporter assays, cytokine profiling, and chromatin associated endpoints; in practice, this compound is commonly used as a reference or test analyte in cell based metabolism and inflammation models, microbiome derived metabolite profiling, and animal studies of gut derived metabolic signatures, while concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.